Search for: "J. A. D. Vs. K. B. F." Results 1 - 20 of 83
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2012, 4:30 am by Susan Cartier Liebel
Visa Waiver Program 214(b) 221(g) NIVs Part II: F-1 Student Visa Change of Status Extension of status 30/60/90 Rule Maintenance of status Unlawful presence F1 student visa Duration of Status (D/S) OPT/CPT NIVs Part III: H-1B Work Visa Eligibility criteria BA vs. [read post]
14 Jan 2021, 11:46 am by Jo Ann Hoffman & Associates, P.A.
(i) Gross Recovery $100,000.00 (ii) Amount of Property Damage $0.00 (iii) Subtotal A (Line a minus Line b) $100,000.00 (iv) Amount Allocated for Loss of Consortium 0% of Line c $0.00 (v) Subtotal B (Line c minus Line d) $100,000.00 (vi) Amount Allocated for Wrongful Death 0% of Line e $0.00 (vii) Amount Allocated for Survival Action 0% of Line e $0.00 (viii) Subtotal C—If Wrongful Death use Line f, if survival action use Line g, otherwise use Subtotal… [read post]
12 May 2022, 1:53 pm by Simon Lester
‘ensure that … it does not ... limit access to an allocation to processors’ under Article 2.30(1)(b); j. [read post]
12 May 2022, 1:53 pm by Simon Lester
‘ensure that … it does not ... limit access to an allocation to processors’ under Article 2.30(1)(b); j. [read post]
24 Aug 2015, 5:01 pm by Law Lady
REYNOLDS TOBACCO COMPANY a foreign corporation, LIGGETT GROUP, LLC, a foreign corporation, f/k/a LIGGETT GROUP, INC., f/k/a LIGGETT & MYERS TOBACCO COMPANY and VECTOR GROUP LTD, INC., f/k/a BROOKE GROUP, LTD, a foreign corporation, Appellees/Cross-Appellants. 4th DistrictThe Law Lady. [read post]
19 May 2017, 7:10 am by Nico Cordes
Die jüngsten der Kammer bekannten Entscheidungen stammen aus den Jahren 2011 und 2012: T 239/08, T 2135/08, T 1600/09, T 207/10, T 648/10 und T 747/10. [read post]
28 Nov 2011, 1:59 am
 The survey did not differentiate between raw milk consumed on the farm vs. purchased by a customer. [read post]
6 Feb 2014, 10:16 am
This brief supports a petition for review by the Wisconsin Supreme Court, and it’s filed on behalf of the Electronic Frontier Foundation in In the Interest of Kaleb K. [read post]
29 Jul 2013, 7:45 am by Schachtman
Pharmaceutical manufacturers are particularly vulnerable to securities fraud claims arising from the manufacturers’ pronouncements about safety or efficacy, the evidence for which is often statistical in nature. [read post]